Literature DB >> 23873699

Trabecular bone score (TBS) predicts vertebral fractures in Japanese women over 10 years independently of bone density and prevalent vertebral deformity: the Japanese Population-Based Osteoporosis (JPOS) cohort study.

Masayuki Iki1, Junko Tamaki, Eiko Kadowaki, Yuho Sato, Namiraa Dongmei, Renaud Winzenrieth, Sadanobu Kagamimori, Yoshiko Kagawa, Hideo Yoneshima.   

Abstract

Bone strength is predominantly determined by bone density, but bone microarchitecture also plays an important role. We examined whether trabecular bone score (TBS) predicts the risk of vertebral fractures in a Japanese female cohort. Of 1950 randomly selected women aged 15 to 79 years, we analyzed data from 665 women aged 50 years and older, who completed the baseline study and at least one follow-up survey over 10 years, and who had no conditions affecting bone metabolism. Each survey included spinal imaging by dual-energy X-ray absorptiometry (DXA) for vertebral fracture assessment and spine areal bone mineral density (aBMD) measurement. TBS was obtained from spine DXA scans archived in the baseline study. Incident vertebral fracture was determined when vertebral height was reduced by 20% or more and satisfied McCloskey-Kanis criteria or Genant's grade 2 fracture at follow-up. Among eligible women (mean age 64.1 ± 8.1 years), 92 suffered incident vertebral fractures (16.7/10(3) person-years). These women were older with lower aBMD and TBS values relative to those without fractures. The unadjusted odds ratio of vertebral fractures for one standard deviation decrease in TBS was 1.98 (95% confidence interval [CI] 1.56, 2.51) and remained significant (1.64, 95% CI 1.25, 2.15) after adjusting for aBMD. The area under the receiver operating characteristic curve of TBS and aBMD combined was 0.700 for vertebral fracture prediction and was not significantly greater than that of aBMD alone (0.673). However, reclassification improvement measures indicated that TBS and aBMD combined significantly improved risk prediction accuracy compared with aBMD alone. Further inclusion of age and prevalent vertebral deformity in the model improved vertebral fracture prediction, and TBS remained significant in the model. Thus, lower TBS was associated with higher risk of vertebral fracture over 10 years independently of aBMD and clinical risk factors including prevalent vertebral deformity. TBS could effectively improve fracture risk assessment in clinical settings.
© 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  DXA; FRACTURE RISK ASSESSMENT; GENERAL POPULATION STUDIES; OSTEOPOROSIS

Mesh:

Year:  2014        PMID: 23873699     DOI: 10.1002/jbmr.2048

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  52 in total

1.  Regional body fat depots differently affect bone microarchitecture in postmenopausal Korean women.

Authors:  J H Kim; H J Choi; E J Ku; A R Hong; K M Kim; S W Kim; N H Cho; C S Shin
Journal:  Osteoporos Int       Date:  2015-10-16       Impact factor: 4.507

2.  Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.

Authors:  A R Hong; J H Kim; K H Lee; T Y Kim; S A Im; T Y Kim; H G Moon; W S Han; D Y Noh; S W Kim; C S Shin
Journal:  Osteoporos Int       Date:  2017-01-12       Impact factor: 4.507

Review 3.  Utility of the trabecular bone score (TBS) in secondary osteoporosis.

Authors:  Fabio M Ulivieri; Barbara C Silva; Francesco Sardanelli; Didier Hans; John P Bilezikian; Renata Caudarella
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

Review 4.  Bone Health During the Menopause Transition and Beyond.

Authors:  Arun S Karlamangla; Sherri-Ann M Burnett-Bowie; Carolyn J Crandall
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

5.  Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.

Authors:  C Senn; B Günther; A W Popp; R Perrelet; D Hans; K Lippuner
Journal:  Osteoporos Int       Date:  2014-04-24       Impact factor: 4.507

Review 6.  Hyperparathyroidism and Bone Health.

Authors:  Francisco Bandeira; Sara Cassibba
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

7.  Trabecular bone score: a useful clinical tool for the evaluation of skeletal health in women of short stature.

Authors:  Pedro Paulo Martins Alvarenga; Barbara Campolina Silva; Mariana Picoli Diniz; Milena Bellei Leite; Caroline Alves Moreira da Silva; Jessica de Cássia Mendes Eleutério; Maria Marta Sarquis Soares; John P Bilezikian; Bruno Muzzi Camargos
Journal:  Endocrine       Date:  2019-07-13       Impact factor: 3.633

8.  Perceived age is associated with bone status in women aged 25-93 years.

Authors:  Barbara Rubek Nielsen; Allan Linneberg; Kaare Christensen; Peter Schwarz
Journal:  Age (Dordr)       Date:  2015-10-20

9.  Premenopausal and early postmenopausal trabecular bone score (TBS) and fracture risk: Study of Women's Health Across the Nation (SWAN).

Authors:  Gail A Greendale; MeiHua Huang; Jane A Cauley; Sioban Harlow; Joel S Finkelstein; Arun S Karlamangla
Journal:  Bone       Date:  2020-07-27       Impact factor: 4.398

10.  The added value of trabecular bone score to FRAX® to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.

Authors:  Y Su; J Leung; D Hans; O Lamy; T Kwok
Journal:  Osteoporos Int       Date:  2016-08-26       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.